GLP-1 receptor agonist discontinuation

Papers on GLP-1 receptor agonist discontinuation

2 papers1 new in 30 days

Tuesday, November 10

The Lancet Regional Health Europe

Stopping some diabetes drugs linked to heart events and deaths

The combined rate of heart attack, stroke or death was 2.01 times as high among people who stopped treatment as among those who continued.The combined rate of heart attack, stroke or death was 2.01 times as high among people who stopped treatment as among those who continued.

Figure from The Lancet Regional Health Europe
Cohort studyType 2 diabetes

Friday, March 27